SOPHiA GENETICS S.A.
SOPH
NASDAQ·Healthcare·Medical - Healthcare Information Services·Mkt cap $694.7M
$8.14
▼ -1.69%
P/E
-7.08
Mkt Cap
$694.7M
52-Wk Range
$3.10–$8.98
52-Week Range
$3.10 - $8.98
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Up 141.4% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
No bull reasons captured for this rating yet.
Bear Case
1 risk
- Average volatility.
Growth
Moderate growth ahead
Value
Deep value opportunity - significant discount to sector peers
Momentum
Hot
+73.2% over 3m
Quality
Excellent
Solid business
Dividend
None
No dividend
Smart-money signal
Who's buying SOPH right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Recent earnings results
AI-summarized recap of last quarter, plus the surprise on every print.
Next: Nov 3, 2026
AUG 4, 2026
Reported EPS of -$0.26 vs -$0.21 consensus (-23.8% surprise). Revenue of $23.3M vs $21.7M expected (+7.3%).
EPS surprise · last 4Q
0 of 1 beats
Estimate
Actual
Q3 26
-23.8%
Revenue trend · last 8Q
—
—
—
—
+23%
+22%
+22%
+27%
Q3 24
Q4 24
Q1 25
Q2 25
Q3 25
Q4 25
Q1 26
Q2 26
$15.9M
$17.7M
$17.8M
$18.3M
$19.5M
$21.7M
$21.7M
$23.3M
Margins · last 8Q
Profit
-95.9%
Wall Street consensus
2 analysts · 100% Buy
Live ratings and price targets aggregated across covering analysts.
Buy
100%
Hold
0%
Sell
0%
Median Price Target
—
Latest: BTIG · Aug 5, 2026
vs Industry
How SOPH stacks vs Medical - Healthcare Information Services
Stock metrics vs industry averages. Green = better than industry.
Industry comparison data unavailable for this stock.